These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 35832472)
1. Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma. Ermiah E; Eddfair M; Abdulrahman O; Elfagieh M; Jebriel A; Al-Sharif M; Assidi M; Buhmeida A Mol Clin Oncol; 2022 Aug; 17(2):126. PubMed ID: 35832472 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma. Gong Y; Song L; Ou L; Lu YY; Huang X; Zeng Q Iran J Med Sci; 2023 Jul; 48(4):401-413. PubMed ID: 37456201 [TBL] [Abstract][Full Text] [Related]
3. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study. Distler M; Pilarsky E; Kersting S; Grützmann R Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419 [TBL] [Abstract][Full Text] [Related]
4. Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis. van Manen L; Groen JV; Putter H; Vahrmeijer AL; Swijnenburg RJ; Bonsing BA; Mieog JSD Biomarkers; 2020 Mar; 25(2):186-193. PubMed ID: 32009482 [No Abstract] [Full Text] [Related]
5. Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer. Wu L; Huang P; Wang F; Li D; Xie E; Zhang Y; Pan S Ann Transl Med; 2015 Dec; 3(21):328. PubMed ID: 26734638 [TBL] [Abstract][Full Text] [Related]
6. Stage-Specific Value of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Serum Levels on Survival and Recurrence in Pancreatic Cancer: A Single Center Study and Meta-Analysis. van Manen L; Groen JV; Putter H; Pichler M; Vahrmeijer AL; Bonsing BA; Mieog JSD Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066393 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms]. Chen L; Zhang Y; Chen M; Chen J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990 [TBL] [Abstract][Full Text] [Related]
8. ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma. Li SS; Zhou CY; Liao R; Xiong L; Weng NN; Zhao YQ; Mason C; Gou HF; Yi C; Zhu Q Medicine (Baltimore); 2020 Apr; 99(14):e19413. PubMed ID: 32243360 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma. Chung HW; Lim JB J Transl Med; 2014 Apr; 12():102. PubMed ID: 24745825 [TBL] [Abstract][Full Text] [Related]
10. Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort. Zhou G; Liu X; Wang X; Jin D; Chen Y; Li G; Li C; Fu D; Xu W; Wang X Onco Targets Ther; 2017; 10():1199-1206. PubMed ID: 28280354 [TBL] [Abstract][Full Text] [Related]
11. Predictive Early Recurrence Factors of Preoperative Clinicophysiological Findings in Pancreatic Cancer. Suzuki S; Shimoda M; Shimazaki J; Maruyama T; Oshiro Y; Nishida K; Sahara Y; Nagakawa Y; Tsuchida A Eur Surg Res; 2018; 59(5-6):329-338. PubMed ID: 30453288 [TBL] [Abstract][Full Text] [Related]
12. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy. Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876 [TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST and CA19-9/γ-GGT for jaundiced PDAC patients). Huang X; Lu Z; Zhang K; Wang G; Cai B; Wu P; Yin J; Miao Y; Jiang K Pancreatology; 2021 May; ():. PubMed ID: 34090807 [TBL] [Abstract][Full Text] [Related]
14. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815 [TBL] [Abstract][Full Text] [Related]
15. Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. Chung HW; Lim JB; Jang S; Lee KJ; Park KH; Song SY Cancer Sci; 2012 Sep; 103(9):1714-21. PubMed ID: 22703527 [TBL] [Abstract][Full Text] [Related]
16. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. Ishigami S; Natsugoe S; Hokita S; Che X; Tokuda K; Nakajo A; Iwashige H; Tokushige M; Watanabe T; Takao S; Aikou T J Clin Gastroenterol; 2001 Jan; 32(1):41-4. PubMed ID: 11154168 [TBL] [Abstract][Full Text] [Related]
17. Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma. Gu X; Zhou R; Li C; Liu R; Zhao Z; Gao Y; Xu Y BMC Cancer; 2019 May; 19(1):456. PubMed ID: 31092213 [TBL] [Abstract][Full Text] [Related]
18. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer]. Qian X; Wang H; Ren Z; Jin F; Pan SY Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062 [No Abstract] [Full Text] [Related]
19. The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection. Lee EC; Yang JY; Lee KG; Oh SY; Suh YS; Kong SH; Yang HK; Lee HJ J Gastric Cancer; 2014 Dec; 14(4):221-8. PubMed ID: 25580353 [TBL] [Abstract][Full Text] [Related]
20. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]